Immunity Journal – Bias and Credibility

Immunity Journal - Pro Science - Least Biased - Medicine - Credible

Factual Reporting: High - Credible - Reliable


PRO-SCIENCE

These sources consist of legitimate science or are evidence-based through credible scientific sourcing.  Legitimate science follows the scientific method, is unbiased, and does not use emotional words.  These sources also respect the consensus of experts in the given scientific field and strive to publish peer-reviewed science. Some sources in this category may have a slight political bias but adhere to scientific principles. See all Pro-Science sources.

  • Overall, we rate Immunity Journal as a Pro-Science journal. We also rate them High for factual reporting due to a clean fact check record.

Detailed Report

Bias Rating: PRO-SCIENCE
Factual Reporting: HIGH
Country: USA
MBFC’s Country Freedom Rating: MOSTLY FREE
Media Type: Journal
Traffic/Popularity: Minimal Traffic

MBFC Credibility Rating: HIGH CREDIBILITY

History

Immunity Journal is a peer-reviewed open-access journal published by Cell Press that covers the Immune System. According to its about page, “Immunity publishes papers that report the most important advances in immunology research. The range of subjects includes, but is not limited to, immune cell development and senescence, signal transduction, gene regulation, innate and adaptive immunity, autoimmunity, infectious disease, allergy and asthma, transplantation, and tumor immunology.

Cell Press, based in Cambridge, Massachusetts, publishes over 50 scientific journals. Cell Press Journals are 50% open-access as of 2023.

Read our profile on the United States media and government.

Funded by / Ownership

Immunity Journal is published by Cell Press which is a subsidiary of Elsevier, a Dutch information and analytics company and one of the world’s foremost providers of scientific, technical, and medical information. It was established in 1880 as a publishing company. Elsevier’s parent company is RELX plc, a British multinational information and analytics company headquartered in London, England. The journal generates revenue through subscription fees and fees for open-access publishing.

Analysis / Bias

Immunity Journal is a hybrid (some open-access) journal that publishes information and research on the immune system. The journal primarily publishes research such as this: Single-cell protein expression profiling resolves circulating and resident memory T cell diversity across tissues and infection contexts.



Cell Press is an open-access/hybrid publisher of scientific journals. There are two types of Open Access Journals, legitimate and predatory, both of which charge the author for publication. Predatory journals often lack peer review and are generally considered not credible. The Immunity Journal is considered a legitimate, open-access publisher that is frequently indexed in PubMed. However, Cell Press has been criticized for retracting some studies.

Although Cell Press has retracted some studies in other publications, Immunity Journal publishes credible scientific studies that are factual and appropriately peer-reviewed.

Failed Fact Checks

  • None in the Last 5 years

Overall, we rate Immunity Journal as a Pro-Science journal. We also rate them High for factual reporting due to a clean fact check record. (D. Van Zandt 07/27/2023)

Source: https://www.cell.com/immunity/

Last Updated on July 27, 2023 by Media Bias Fact Check



Left vs. Right Bias: How we rate the bias of media sources

Found this insightful? Please consider sharing on your Social Media: